Papers

2

Total Citations

16

H-Index

2

About

Dr. Ming Cui is a pioneering surgeon-scientist advancing the field of minimally invasive pancreatic surgery, with a primary focus on comparing robotic and laparoscopic approaches for pancreatic cancer. His most influential work, a 2024 study evaluating surgical efficacy between robotic and laparoscopic pancreaticoduodenectomy, has garnered 12 citations, establishing a critical benchmark for operative outcomes. Dr. Cui further refined this analysis through propensity score matching and learning curve assessments in 2025, demonstrating that robotic techniques may offer superior perioperative results with manageable learning curves. His research directly addresses the pressing need for evidence-based surgical decision-making in complex hepatobiliary malignancies, providing granular data on blood loss, lymph node harvest, and recovery times. By systematically quantifying the advantages of robotic platforms over traditional laparoscopy, Dr. Cui’s contributions are shaping training protocols and operative standards worldwide. His work stands at the intersection of surgical innovation and rigorous comparative effectiveness, offering actionable insights for both experienced pancreatic surgeons and trainees navigating the adoption of advanced robotic technologies.

Research Focus

Key Achievements

2
H-Index
2
Papers
16
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Versus Laparoscopic Pancreaticoduodenectomy for Pancreatic Cancer: Evaluation and Analysis of Surgical Efficacy
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago